DWTX Dogwood Therapeutics, Inc. Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
DWTX
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 8
- List Date
- 2020-12-17
- CIK
- 0001818844
- Next Earnings
- 2026-11-05
- EPS Forecast
- ($0.15) (1 est.)
- Headquarters
- Alpharetta, GA
- Homepage
- https://www.virios.com
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | -- | 397.61% | -34.20% | 181.71% |
| Feb | -- | -66.22% | -2.73% | -34.48% |
| Mar | -- | 16.78% | -25.18% | -4.20% |
| Apr | -- | 11.38% | -32.86% | -10.74% |
| May | -- | -3.36% | 15.75% | 6.20% |
| Jun | -- | -9.49% | -5.29% | -7.39% |
| Jul | -- | -2.32% | 7.89% | 2.79% |
| Aug | -- | 2.27% | 50.88% | 26.58% |
| Sep | -- | 60.08% | -48.67% | 5.70% |
| Oct | 53.71% | -12.16% | -22.38%* | 6.39% |
| Nov | -45.08% | 4.82% | -- | -20.13% |
| Dec | 2.47% | -34.49% | -- | -16.01% |
| Total | -13.50% | 84.46% | -77.14% | -2.06% |
* Only 3 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.31
SMA 50: $1.76
SMA 200: $2.01
Current: $1.11
EMA 12: $1.22
EMA 26: $1.37
MACD: -0.1549 | Signal: -0.0010
BEARISH
ADX (14): 20.52
WEAK TREND
+DI: 16.25
−DI: 23.36
Momentum Oscillators
RSI (14): 23.77
OVERSOLD
Stoch %K: 5.15
Stoch %D: 4.54
Williams %R: -91.49
Volume & Volatility
BB Upper: $1.57
BB Lower: $1.05
NEUTRAL
OBV: 253,622,003
Vol SMA 20: 73,935
Vol ROC: -10.49%
ATR: $0.13
True Range: $0.09
HV 20: 47.3%
HV 30: 48.5%
HV 60: 74.9%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Click Frenzy-Pro™ for an AI analysis of this ticker.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
All DWTX news →
DWTX Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.1873
Alpha: -144.59%
Correlation: 0.1756
R-Squared: 3.1%
Stock Volatility: 86.2%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Notable investors who own DWTX
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $550K | #3137 of 3716 | new | 13F | |
| Citadel Hedge fund Ken Griffin | $19K | #6178 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
DWTX Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
DWTX Insider Trading (Form 4)
Latest: 2026-06-17Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Rosa Abel De La | Director | Grant (A) | +16,800 opt | — | EDGAR | |
| 2026-06-17 | John C Thomas | Director | Grant (A) | +16,800 opt | — | EDGAR | |
| 2026-06-17 | David R Keefer | Director | Grant (A) | +16,800 opt | — | EDGAR | |
| 2026-06-17 | Richard James Whitley | Director | Grant (A) | +16,800 opt | — | EDGAR | |
| 2026-03-06 | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant (A) | +82,500 opt | — | EDGAR | |
| 2026-03-06 | Gregory Scott Duncan | CHIEF EXECUTIVE OFFICER | Grant (A) | +330,000 opt | — | EDGAR | |
| 2026-03-06 | Angela Walsh | Chief Financial Officer | Grant (A) | +82,500 opt | — | EDGAR | |
| 2026-03-06 | Ralph Grosswald | SVP OF OPERATIONS | Grant (A) | +82,500 opt | — | EDGAR | |
| 2025-12-05 | Angela Walsh | Chief Financial Officer | Grant (A) | +150,000 opt | — | EDGAR | |
| 2025-12-05 | Roger Michael Gendreau | CHIEF MEDICAL OFFICER | Grant (A) | +150,000 opt | — | EDGAR | |
| 2025-12-05 | Gregory Scott Duncan | CHIEF EXECUTIVE OFFICER | Grant (A) | +460,000 opt | — | EDGAR | |
| 2025-12-05 | Ralph Grosswald | SVP OF OPERATIONS | Grant (A) | +150,000 opt | — | EDGAR | |
| 2025-11-25 | Sealbond Ltd | Director | Conv (C) | +73,360,764 | — | EDGAR | |
| 2025-07-01 | Richard James Whitley | Director | Grant (A) | +2,362 opt | — | EDGAR | |
| 2025-07-01 | Gregory Scott Duncan | CHIEF EXECUTIVE OFFICER | Grant (A) | +40,000 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
DWTX Insider Holdings
1 insider · @ $1.11
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sealbond Ltd | Director | 24,664,971 | $27.38M | $0 | 1 | 2025-11-25 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
DWTX Board & Officers
As of SEC filings through Jun 17, 2026Directors 10
- David R Keefer · since Dec 16, 2020
- Gregory Scott Duncan · since Dec 16, 2020
- John C Thomas · since Dec 16, 2020
- Richard James Whitley · since Dec 16, 2020
- Rosa Abel De La · since Dec 16, 2020
- Kean Meng Melvin Toh · since Oct 7, 2024
- Ying Choi Alan Abel Yu · since Oct 7, 2024
- Conjoint Inc. (entity) · since Mar 12, 2025
- CK Life Sciences Intl (Holdings) Inc (entity) · listed since Mar 2025
- Sealbond Ltd (entity) · listed since Nov 2025
Officers 4
- Gregory Scott Duncan · Chief Executive Officer · since Dec 16, 2020
- Angela Walsh · Chief Financial Officer · listed since Jul 2025
- Roger Michael Gendreau · Chief Medical Officer · since Dec 16, 2020
- Ralph Grosswald · SVP of Operations · listed since Jun 2022
10% owners 3
- CK Life Sciences Intl (Holdings) Inc (entity) · since Oct 7, 2024
- Conjoint Inc. (entity) · since Mar 12, 2025
- Sealbond Ltd (entity) · since Oct 7, 2024
Changes in the last 10 years (23)
| Nov 25, 2025 | Sealbond Ltd first listed as a director in an SEC filing |
| Jul 1, 2025 | Angela Walsh listed as Chief Financial Officer (previously SVP of Finance) in SEC filings |
| Mar 17, 2025 | CK Life Sciences Intl (Holdings) Inc first listed as a director in an SEC filing |
| Mar 12, 2025 | Conjoint Inc. became a director |
| Mar 12, 2025 | Conjoint Inc. became a 10% owner |
| Oct 7, 2024 | Ying Choi Alan Abel Yu became a director |
| Oct 7, 2024 | Sealbond Ltd became a 10% owner |
| Oct 7, 2024 | Kean Meng Melvin Toh became a director |
| Oct 7, 2024 | CK Life Sciences Intl (Holdings) Inc became a 10% owner |
| Oct 4, 2024 | The company announced the departure of Richard Alan Burch from the board in an SEC filing |
| Jun 30, 2022 | Ralph Grosswald listed as SVP of Operations (previously Vice President of Operations) in SEC filings |
| Jun 22, 2021 | Angela Walsh listed as SVP of Finance (previously VP of Finance) in SEC filings |
| Dec 16, 2020 | William Pridgen became a director |
| Dec 16, 2020 | Rosa Abel De La became a director |
| Dec 16, 2020 | Roger Michael Gendreau became Chief Medical Officer |
| Dec 16, 2020 | Richard James Whitley became a director |
| Dec 16, 2020 | Richard Alan Burch became a director |
| Dec 16, 2020 | Ralph Grosswald became Vice President of Operations |
| Dec 16, 2020 | John C Thomas became a director |
| Dec 16, 2020 | Gregory Scott Duncan became a director |
| Dec 16, 2020 | Gregory Scott Duncan became Chief Executive Officer |
| Dec 16, 2020 | David R Keefer became a director |
| Dec 16, 2020 | Angela Walsh became VP of Finance |
Not reported recently (1)
- William Pridgen · Last reported as a director in an SEC filing dated Feb 28, 2024
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
2 ETFs hold DWTX
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.